Taiwan FDA registration fed137af865e594edb20ca9bc2e509f7
Immediate confirmation of the cell membrane glycoprotein receptor IIb/IIIa assay set
TW: 立即確認 細胞膜醣蛋白接受器 IIb/IIIa檢測試劑組
Taiwan·Risk Class 2·ACCUMETRICS, INC.·Registered Mar 03, 2011 – Mar 03, 2016CancelledRegistration details
- Analysis ID
- fed137af865e594edb20ca9bc2e509f7
- Customs Code
- DHA00602195104
Company information
- Manufacturer
- ACCUMETRICS, INC.
- Manufacturer Country
- United States
- Authorized Representative
- MEDDRAGON TECHNOLOGY CO., LTD.
Product details
- Intended Use
- 立即確認 細胞膜醣蛋白接受器 IIb/IIIa檢測試劑組是一種半定量式全血中血小板功能檢測,測量病人以abciximab或eptifibatide治療後細胞膜醣蛋白接受器 IIb/IIIa的阻斷情形. 臨床醫師於判讀VerifyNow IIb/IIIa assay時應該配合其他臨床與實驗室數據.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.5700 Automated platelet agglutination system
- Import Information
- import
Dates and status
- Registration Date
- Mar 03, 2011
- Expiry Date
- Mar 03, 2016
- Cancellation Date
- May 17, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for Immediate confirmation of the cell membrane glycoprotein receptor IIb/IIIa assay set in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number fed137af865e594edb20ca9bc2e509f7 and manufactured by ACCUMETRICS, INC.. The authorized representative in Taiwan is MEDDRAGON TECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices